Maria C. Allende - Concepedia

Author

Maria C. Allende

National Cancer Institute

Also Known As

M Allende, M C Allende, M. C. Allende, MARIA ALLENDE, Maria Allende, Maria C. Allende, Maria C. Allende, María Allende

Publications

1.1K

Citations

H-Index

Concepts

All Affiliations

National Cancer Institute University of Colorado Denver National Institutes of Health United States Military Academy Stony Brook University

About

Maria C. Allende is an author at National Cancer Institute specializing in medicine, immunology, and vaccination.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	6	6	601
2	Public Health	1	1	134
3	Allergy	1	1	67
4	Critical Care Medicine	1	1	24
5	Emergency Medicine	1	1	24

Maria C. Allende

Publications

892

Citations

H-Index

Page 1

	Year	Citations
Pathogenesis of pulmonary aspergillosis. Granulocytopenia versus cyclosporine and methylprednisolone-induced immunosuppression. Juan Berenguer, Maria C. Allende, J W Lee, American Journal of Respiratory and Critical Care Medicine InflammationAutoimmune DiseaseLung InflammationGranulocyteImmunodeficiencies	1995	187
Safety and immunogenicity of a virus-like particle pandemic influenza A (H1N1) 2009 vaccine in a blinded, randomized, placebo-controlled trial of adults in Mexico Constantino López‐Macías, Eduardo Ferat‐Osorio, Alejandra V. Tenorio-Calvo, Vaccine VaccinationVaccine SafetyCross-protectionPreventive MedicinePlacebo-controlled Trial	2011	134
A phase I study to evaluate a human papillomavirus (HPV) type 18 L1 VLP vaccine Kevin A. Ault, Anna R. Giuliano, Robert P. Edwards, Vaccine VaccinationHuman Papillomavirus VaccinesL1 Vlp VaccineVaccine TargetImmunology	2004	97
Shedding of live vaccine virus, comparative safety, and influenza-specific antibody responses after administration of live attenuated and inactivated trivalent influenza vaccines to HIV-infected children Myron J. Levin, Lin‐Ye Song, Terrence Fenton, Vaccine VaccinationVaccine SafetyVaccine DevelopmentLive Vaccine VirusImmunology	2008	92
Itraconazole for experimental pulmonary aspergillosis: comparison with amphotericin B, interaction with cyclosporin A, and correlation between therapeutic response and itraconazole concentrations in plasma Juan Berenguer, N ALI, Maria C. Allende, Antimicrobial Agents and Chemotherapy	1994	76
Dose-dependent antifungal activity and nephrotoxicity of amphotericin B colloidal dispersion in experimental pulmonary aspergillosis Maria C. Allende, J W Lee, Peter Francis, Antimicrobial Agents and Chemotherapy	1994	69
A Randomized, Controlled, Phase II Trial Comparing Escalating Doses of Subcutaneous Interleukin‐2 plus Antiretrovirals versus Antiretrovirals Alone in Human Immunodeficiency Virus–Infected Patients with CD4<sup>+</sup>Cell Counts ⩾350/mm<sup>3</sup> Marcelo Losso, Waldo Belloso, Sean Emery, The Journal of Infectious Diseases ImmunodeficienciesImmunologyImmunodominanceImmune SystemImmunotherapy	2000	67
Therapeutic monitoring of experimental invasive pulmonary aspergillosis by ultrafast computerized tomography, a novel, noninvasive method for measuring responses to antifungal therapy Thomas J. Walsh, K Garrett, E Feurerstein, Antimicrobial Agents and Chemotherapy	1995	58
Anti-Influenza Serum and Mucosal Antibody Responses After Administration of Live Attenuated or Inactivated Influenza Vaccines to HIV-Infected Children Adriana Weinberg, Lin‐Ye Song, Robert Walker, JAIDS Journal of Acquired Immune Deficiency Syndromes	2010	43
Eligibility and willingness of young Icelandic women to participate in a HPV vaccination trial Thorbjörg Gudmundsdóttir, Laufey Tryggvadóttír, Maria C. Allende, Acta Obstetricia Et Gynecologica Scandinavica	2003	24

Page 1